Study Supports RAS Blocker After AKI, With Close Clinical Monitoring Study Supports RAS Blocker After AKI, With Close Clinical Monitoring

Use of a renin angiotensin system (RAS) blocker after acute kidney injury (AKI) provides protection against death but may be accompanied by higher rates of hospitalization due to renal problems, a new analysis from Canada suggests.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Nephrology News Source Type: news